We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Augmedix Inc (AUGX) USD0.0001

Sell:$1.51 Buy:$1.97 Change: $0.18 (10.00%)
Market closed |  Prices as at close on 1 July 2022 | Switch to live prices |
Change: $0.18 (10.00%)
Market closed |  Prices as at close on 1 July 2022 | Switch to live prices |
Change: $0.18 (10.00%)
Market closed |  Prices as at close on 1 July 2022 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Augmedix Inc (Augmedix) is a technology-enabled healthcare service provider that offers virtual medical documentation services and live clinical support. The Company provides clinicians with dedicated mobile devices (smartphones or smart glass), which enables clinicians to communicate with the Augmedix service platform that is overseen by remotely located medical data specialists (MDS). The Company’s MDSs observe the clinician-patient interaction, through an audio/video stream, and extract the relevant elements of that interaction. The medical note is generated using Augmedix’s Notebuilder software, which incorporates automated speech recognition and natural language processing. Medical notes are then uploaded into the patient’s chart contained within the electronic health record (EHR) system. The EHR system is third-party software licensed by the healthcare clinic or system to manage patient charts.

Contact details

111 Sutter Street, Suite 1300, Suite Ll
United States
+1 (561) 9892208

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$74.07 million
Shares in issue:
37.40 million
Health Care Technology
United States
US dollar

Key personnel

  • Emmanuel Krakaris
    President, Chief Executive Officer, Company Secretary, Director
  • Ian Shakil
    Founder, Director, Chief Strategy Officer
  • Paul Ginocchio
    Chief Financial Officer
  • Sandra Breber
    Chief Operating Officer
  • Saurav Chatterjee
    Chief Technology Officer
  • Jonathan Hawkins
    Chief Revenue Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.